Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
26 May 2026
| 16:10 | 2C-B diffhist +768 MDElliottMD talk contribs (home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean)) | ||||
22 May 2026
|
|
16:47 | 2C-B 5 changes hist +592 [MDElliottMD (5×)] | |||
|
|
16:47 (cur | prev) +27 MDElliottMD talk contribs (Link legal-status field to the USLegal: namespace) | ||||
|
|
03:01 (cur | prev) 0 MDElliottMD talk contribs (Repoint receptor links to the new Receptor: namespace) | ||||
|
|
02:57 (cur | prev) −78 MDElliottMD talk contribs (Repoint CYP2D6/CYP3A4 links to the new Enzyme: namespace) | ||||
|
|
01:40 (cur | prev) +480 MDElliottMD talk contribs (2C-B final link addendum (web-claude, consolidated): merge new links onto the citation-corrected page (5-HT2A/2C/2B receptors, monoamine transporter, Schedule I, Controlled Substances Act, Convention on Psychotropic Substances, Medicines Control Council, Ann Shulgin, Empathogens); psychostimulants house-term fix; propagate the lithium clinical correction into the interactions field) | ||||
|
|
00:09 (cur | prev) +163 MDElliottMD talk contribs (2C-B harm-reduction: clinical correction (pharmacist-claude) - lithium moved out of the serotonin-syndrome list into its own sentence (lithium + psychedelic risk is seizures/severe reactions, not serotonin syndrome)) | ||||
| 01:53 | TiHKAL diffhist −39 MDElliottMD talk contribs (Create stub: TiHKAL (backs internal-linking redlinks; amended linking rule)) | ||||
|
|
00:38 | Category:Tryptamines 2 changes hist +1 [MDElliottMD (2×)] | |||
|
|
00:38 (cur | prev) +1 MDElliottMD talk contribs (Category taxonomy ship: retag plant categories -> Plants) | ||||
|
|
00:36 (cur | prev) 0 MDElliottMD talk contribs (Category taxonomy ship: retag Research Materials -> Research chemicals) | ||||
| 00:38 | Category:Phenethylamines diffhist +1 MDElliottMD talk contribs (Category taxonomy ship: retag plant categories -> Plants) | ||||
| 00:36 | MDMA [pending edits] diffhist −14 MDElliottMD talk contribs (Category taxonomy ship: retag Empathogens / Entactogens -> Empathogens) | ||||
| 00:23 | Template:ShulginsCorner diffhist +131 MDElliottMD talk contribs (Usage doc: remove the 'one or the other, not both' restriction (home-claude's own wording when the template was built, never a directive; Mark retracted it). A page may carry both Corners.) | ||||
| N 00:18 | Drug Enforcement Administration diffhist +690 MDElliottMD talk contribs (Create stub: Drug Enforcement Administration (backs redlinks)) | ||||
21 May 2026
|
|
23:33 | 2C-B 17 changes hist +16,658 [MDElliottMD (17×)] | |||
|
|
23:33 (cur | prev) +102 MDElliottMD talk contribs (2C-B: link the remaining serotonergic-list terms (SNRIs, lithium, dextromethorphan) per pharmacist-claude verification; all 6 now linked) | ||||
|
|
23:31 (cur | prev) +425 MDElliottMD talk contribs (Internal-linking pass on 2C-B (web-claude addendum, corrected): ~18 first-occurrence links across intro/history/pharmacodynamics/dosing/interactions; redlinks for Alexander Shulgin, DEA, Serotonin syndrome per the amended linking rule) | ||||
|
|
23:03 (cur | prev) +3,764 MDElliottMD talk contribs (Populate 2C-B effects field: 60-effect subjective profile (parser-claude handoff), adapted from PsychonautWiki CC BY-SA 4.0, source approved by Mark; all 60 effect slugs verified in pcp_effects) | ||||
|
|
22:58 (cur | prev) −44 MDElliottMD talk contribs (Clear leftover JS-test effect fixture from 2C-B effects field; restore to empty (rev 5173 state) pending a sourcing decision on the effects list) | ||||
|
|
22:57 (cur | prev) +4 MDElliottMD talk contribs Tag: 2017 source edit | ||||
|
|
22:51 (cur | prev) −45 MDElliottMD talk contribs (Removed effect "ref-nausea") Tag: Manual revert | ||||
|
|
22:51 (cur | prev) −45 MDElliottMD talk contribs (Removed effect "ref-nausea") Tags: Manual revert Reverted | ||||
|
|
22:51 (cur | prev) −45 MDElliottMD talk contribs (Removed effect "ref-nausea") Tags: Manual revert Reverted | ||||
|
|
21:52 (cur | prev) +45 MDElliottMD talk contribs (Added effect: Nausea) Tag: Reverted | ||||
|
|
21:51 (cur | prev) +45 MDElliottMD talk contribs (Added effect: Nausea) Tag: Reverted | ||||
|
|
21:44 (cur | prev) +45 MDElliottMD talk contribs (Added effect: Nausea) Tag: Reverted | ||||
|
|
21:43 (cur | prev) +43 MDElliottMD talk contribs (Added effect: Nausea) | ||||
|
|
21:21 (cur | prev) +455 MDElliottMD talk contribs (Retract the citation-driven cut: restore the Europe/Eroxan/South Africa history with [citation needed] markers per Mark's rule (Claude-generated uncitable claims are flagged, not deleted)) | ||||
|
|
21:15 (cur | prev) −312 MDElliottMD talk contribs (Cut uncitable claims from 2C-B history: remove Eroxan brand name and the South Africa / Medicines Control Council passage; keep only what Papaseit 2018 and the DEA rules support) | ||||
|
|
21:11 (cur | prev) +1,115 MDElliottMD talk contribs (Citation pass on 2C-B history: add DEA Federal Register rules (59 FR 671, 60 FR 28718), Papaseit 2018 and Blok 2020 cites; correct the DEA-license account (TiHKAL Invasion), give both 2C-B scheduling dates) | ||||
|
|
20:52 (cur | prev) +11,140 MDElliottMD talk contribs (Build out 2C-B from stub: history, pharmacodynamics, dosing + harm-reduction titration, 5 ShulginsCorner quotes (PiHKAL #20), interactions, Pharmaceutical origin tag) | ||||
|
|
17:26 (cur | prev) −34 MDElliottMD talk contribs (Tier 2 taxonomy consolidation: merge Classic Psychedelics into Classical Psychedelics (Serotonergic)) | ||||